Aenitis Technologies

Aenitis Technologies Overview

Founded 2013
Status Private
Latest Deal Type Grant
Latest Deal Amount $11K
Latest Deal Amount
Investors 6

Aenitis Technologies General Information


Developer of a medical device intended to offer to cell therapies preparations. The company's devices focus on cell therapy units and blood banks' challenges by developing bioprocessing medical devices dedicate to cells therapy manufacturing issues including cells sorting, cells washing and cells isolation, enabling the healthcare industry to get acoustic preparation support for cell therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Primary Office
  • 56 rue Paul Vaillant
  • 77290 Mitry Mory
  • France

Aenitis Technologies Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aenitis Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 02-Dec-2019 $11K 00.000 Completed Generating Revenue
4. Early Stage VC 30-Nov-2017 00.00 00.000 000.00 Completed Generating Revenue
3. Angel (individual) 13-Jul-2016 000.00 00.000 00.000 Completed Startup
2. Seed Round 04-May-2015 $1.09M $1.09M 00.000 Completed Startup
1. Accelerator/Incubator 01-Sep-2013 Completed Startup

Aenitis Technologies Cap Table

To view Aenitis Technologies‘s complete cap table, request access >>
Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 55,850 $1.174274 $21.03 $21.03 1x $21.03 28.16%

Aenitis Technologies Executive Team (4)

Name Title Board Seat Contact Info
Emmanuel Vincent Co-Founder, Chief Executive Officer & Advisor
Jacky Harrouet Chief Financial Officer
Mauricio Hoyos Co-founder & Scientific Advisor
Jean-Luc Aider Scientific Advisor & Co-Founder

Aenitis Technologies Board Members (1)

Name Representing Role Since
Philippe Tramoy Seventure Partners Strategic Board Member 000 0000

Aenitis Technologies Investors (6)

To view Aenitis Technologies‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EIT Health Accelerator/Incubator 000 0000 000000 0
Horizon 2020 Government Minority 000 0000 000000 0
Weaving Invest Venture Capital Minority 000 0000 000000 0
FIST SA Other Minority 000 0000 000000 0
Seventure Partners Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial